Humoral Immune Response to SARS-CoV-2 Vaccination after a Booster Vaccine Dose in Two Kidney Transplant Recipients with Fabry Disease and Variable Secondary Immunosuppressive Regimens

The urgent need to fight the COVID-19 pandemic has accelerated the development of vaccines against SARS-CoV-2 and approval processes. Initial analysis of two-dose regimens with mRNA vaccines reported up to 95% efficacy against the original strain of the SARS-CoV-2 virus. Challenges arose with the ap...

Descripción completa

Detalles Bibliográficos
Autores principales: Bernea, Lavinia, Ailioaie, Oana R., Benhamouda, Nadine, Tartour, Eric, Germain, Dominique P.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708799/
https://www.ncbi.nlm.nih.gov/pubmed/34960158
http://dx.doi.org/10.3390/vaccines9121412

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8708799/
https://www.ncbi.nlm.nih.gov/pubmed/34960158
http://dx.doi.org/10.3390/vaccines9121412

Ejemplares similares